9001cc½ðɳÒÔ³ÏΪ±¾

ÊÖ³Öʽ¹âÆ×ÒÇÊÖ³ÖʽºÏ½ðÆÊÎöÒǺϽðÆÊÎöÒÇ
¹ÉƱ´úÂ룺300165 ÆóÒµÓÊÏä Ͷ×ÊÕß¹ØÏµ
9001cc½ðɳÒÔ³ÏΪ±¾(Öйú)ÓÐÏÞ9001cc½ðɳÒÔ³ÏΪ±¾¹«Ë¾

Ò½Ò©

ÄúÄ¿½ñËùÔÚÒ³£ºÊ×Ò³ > ½â¾ö¼Æ»® > Ò½Ò©

ÆøÏàÉ«Æ×-ÖÊÆ×ÁªÓ÷¨£¨GC-MS£©²âÊÔÒ½ÁÆÆ÷е²úÆ·ÖеÄTOTM

Ðû²¼ÈÕÆÚ£º2020/9/24 10:36:52  µã»÷´ÎÊý£º51614

Æ«±½ÈýËáÈýÐÁõ¥(TOTM), ÒòÆäÓÅÒìµÄËÜ»¯ÐÔ¡¢ÄÍǨáãÐÔ¡¢Ä͸ßÎÂÒÔ¼°µÍ¶¾ÐÔ£¬±»ÒÔΪÊÇ¿ÉÌæ»»ÁÚ±½¶þ¼×Ëá¶þ(2-ÒÒ»ù¼º»ù)õ¥(DEHP)µÄÒ»ÖÖÓÅÁ¼ÔöËܼÁ ¡£Ö»¹ÜÏÖÔÚûÓгä·ÖÖ¤¾ÝÏÔʾҽÁÆÆ÷еÖÐTOTM¶ÔÈËÌåÓÐÏÔÖøµÄÓ°Ï죬¿ÉÊÇ£¬¶¯ÎïʵÑéÅú×¢TOTMÔÚ´úлµÄÀú³ÌÖлá»ýÀÛÔÚ×éÖ¯Àï ¡£¿¼²ìTOTMµÄÈܳöÁ¿µÄÓ°ÏìÒòËØÒÔ¼°ÈËÌå¿É½ÓÊܵÄÄÍÊÜÏÞÁ¿£¬ÌØÊâÊÇһЩÐÂÉú¶ù¡¢ÓÐÉí»ò²¸È鸾ŮµÈ¸ßÃô¸ÐȺÌåÊÇÊ®·ÖÐëÒªµÄ ¡£½ÓÄÉGC-MS 6800ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ£¬¶ÔÒ½ÁÆÆ÷еPVCÖÐTOTM¾ÙÐÐ¼à¿Ø£¬»ñµÃÁ˽ÏÁ¿Öª×ãµÄ²âÊÔЧ¹û ¡£


1.ÒÇÆ÷¼ò½é

GC-MS 6800ÊÇ9001cc½ðɳÒÔ³ÏΪ±¾ÒÇÆ÷È«ÐÄ´òÔìµÄÒ»¿î¸ßÐÔ¼Û±ÈÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ£¬¾ßÓÐÍêÈ«µÄ×ÔÖ÷֪ʶ²úȨ£¬ÓµÓжàÏîרÀûÊÖÒÕ£¬¿ÉÆÕ±éÓ¦ÓÃÓڸ߷Ö×ÓÖÊÁÏ¡¢ÇéÐα£»¤¡¢µç×ÓµçÆ÷¡¢Ò½Ò©¡¢Ê¯ÓÍ»¯¹¤¡¢Ê³ÎïÇå¾²¡¢·Ä֯Ƥ¸ïµÈ¶àÐÐÒµÖÐÓк¦ÎïÖʵļì²â ¡£


9001cc½ðɳÒÔ³ÏΪ±¾(Öйú)ÓÐÏÞ9001cc½ðɳÒÔ³ÏΪ±¾¹«Ë¾

ͼ1.GC-MS 6800ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇÍâ¹Ûͼ


2.ʵÑ鲿·Ö

2.1 ²âÊÔÔ­Àí

ÑùÆ·¾­¼ôËéºó׼ȷ³ÆÈ¡£¬¾­ÒÒËáÒÒõ¥ÝÍÈ¡¹ýÂ˺ó£¬ÓÃGCMSÆÊÎö ¡£ÒÀ¾ÝÄ¿µÄ»¯ºÏÎïµÄ±£´æÊ±¼äºÍ±ê×¼ÖÊÆ×ͼ»òÌØÕ÷Àë×Ó¶¨ÐÔ£¬ÓÃÍâ±ê·¨¶¨Á¿ ¡£

2.2Ö÷ÒªÒÇÆ÷×°±¸¡¢ºÄ²ÄºÍÊÔ¼Á

GC-MS 6800 ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ£¬ÅäÓÐEI£¨9001cc½ðɳÒÔ³ÏΪ±¾£©£»

ÆÊÎöÌìÆ½£º¾«¶ÈÊ®Íò·ÖÖ®Ò»£¨BT 125D£¬Èü¶àÀû˹¿ÆÑ§ÒÇÆ÷£¨±±¾©£©ÓÐÏÞ¹«Ë¾£©£»

Æ«±½ÈýËáÈýÐÁõ¥£¨TOTM£©±ê׼Ʒ£º¦Ñ=1000mg/L £¨¹ú¼Ò±ê×¼ÎïÖÊÍø£©£»

ÒÒËáÒÒõ¥£ºHPLC¼¶£¨Ä¬¿Ë£© ¡£

Õý¼ºÍ飺HPLC¼¶£¨Ä¬¿Ë£© ¡£

2.2 ÒÇÆ÷²âÊÔÌõ¼þ

É«Æ×Öù£ºDB-5MS£¬15m¡Á0.25mm¡Á0.1¦Ìm£»

ÖùÏä³ÌÐòÉýÎÂÌõ¼þ£º³õʼζÈ100¡æ£¬20¡æ/minÉýÖÁ280¡æ¼á³Ö6min£»

½øÑù·½·¨£º²»·ÖÁ÷½øÑù£¬²»·ÖÁ÷ʱ¼ä1min£¬·ÖÁ÷±È20:1£»

½øÑùÁ¿£º1.0¦ÌL£»

½øÑù¿Úζȣº280¡æ£»

ÆøÖʽӿÚζȣº280¡æ£»

Àë×ÓԴζȣº280¡æ£»

ÔØÆø£ºº¤Æø£¬´¿¶È¡Ý99.999%£¬Á÷ËÙ1.0mL/min£»

µçÀë·½·¨£ºEI£»

µçÀëÄÜÁ¿£º70eV£»

ÈܼÁÇгýʱ¼ä£º4min£»

²â¶¨·½·¨£ºTIC£¨FULL SCAN£©¶¨ÐÔ£¨É¨Ãè¹æÄ££º45-450amu£©£¬SIMģʽ¶¨Á¿ ¡£


3.²âÊÔЧ¹û

3.1 TOTM±ê×¼ÎïÖÊ×é·Ö¶¨ÐÔЧ¹û

9001cc½ðɳÒÔ³ÏΪ±¾(Öйú)ÓÐÏÞ9001cc½ðɳÒÔ³ÏΪ±¾¹«Ë¾

1.TOTM

ͼ2. TOTM±ê×¼ÎïÖÊ×ÜÀë×ÓÁ÷É«Æ×ͼ

9001cc½ðɳÒÔ³ÏΪ±¾(Öйú)ÓÐÏÞ9001cc½ðɳÒÔ³ÏΪ±¾¹«Ë¾

ͼ3.TOTMÖÊÆ×ͼ


±í1.Ä¿µÄÎï»ù±¾²âÊÔÐÅÏ¢

»¯ºÏÎï

Ó¢ÎÄÃû³Æ

CASºÅ

ÌØÕ÷Àë×Ó

Æ«±½ÈýËáÈýÐÁõ¥

TOTM

3319-31-1

350* 306 323 193


3.2 ÑùÆ·²âÊÔ

9001cc½ðɳÒÔ³ÏΪ±¾(Öйú)ÓÐÏÞ9001cc½ðɳÒÔ³ÏΪ±¾¹«Ë¾

ͼ4.ÏÖʵÑùÆ·²âÊÔͼ

4.×ܽá

±¾ÊµÑé½ÓÄÉÆøÏàÉ«Æ×ÖÊÆ×ÁªÓ÷¨£¨GC-MS£©£¬ÔÚSIMɨÃèģʽ϶ÔÒ½ÁÆÆ÷еÖÐTOTM¾ÙÐж¨ÐÔ¶¨Á¿²âÊÔ£¬ÒªÁìÎȹ̿ɿ¿£¬ÏßÐÔ¹æÄ£ºÃ£¬Ñ¸Ëٶȸߣ¬ÊÜÔÓÖÊ·å×ÌÈÅС£¬ÍêÈ«ÇкϲâÊÔÒªÇó ¡£

5£®²Î¿¼ÎÄÏ×

[1] HG/T 3874-2018 ¹¤ÒµÆ«±½ÈýËáÈý£¨2-ÒÒ»ù¼º»ù£©õ¥£¨TOTM£©

[2] GB/T 16886.17-2005 Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ17²¿·Ö£º¿ÉÁ¤ÂËÎïÔÊÐíÏÞÁ¿µÄ½¨Éè

[3] IS0 10993-17:2002 Biological evaluation of medical devices ¨C Part 17: Establishment of allowable limits for leachable substances 

Ïà¹Ø²úÆ·

ÁªÏµ9001cc½ðɳÒÔ³ÏΪ±¾

Ïàʶ¸ü¶àÏêϸÐÅÏ¢£¬ÇëÖµç
400-7102-888
·ÇÊÂÇéʱ¼ä·þÎñÈÈÏß
139 1323 1381
¸øÎÒÃÇÁôÑÔ
ÔÚÏßÁôÑÔ
΢ÐÅÊÛºó·þÎñ¶þάÂë

ÍøÕ¾µØÍ¼